Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells

Luca Gerosa(Harvard University), Peter K. Sorger(Harvard University Press), Jeremy L. Muhlich(Harvard University), Jia-Yun Chen(Harvard University), Thomas S.C. Ng(Brigham and Women's Hospital), Rainer H. Köhler(Massachusetts General Hospital), H Wiley(Pacific Northwest National Laboratory), Gabriela Sánchez(Kaiser Permanente), Sreeram Vallabhaneni(Harvard University), Miles A. Miller(Harvard University), Douglas A. Lauffenburger(Harvard University), Lily A. Chylek(Los Alamos National Laboratory), Ralph Weissleder(Massachusetts General Hospital), Carrie Nicora(Pacific Northwest National Laboratory), Tujin Shi(Pacific Northwest National Laboratory), Weijun Qian(Pacific Northwest National Laboratory), Denis Schapiro(Heidelberg University), Allison Claas(Massachusetts Institute of Technology), Mariya Atanasova(Harvard University), Gregory J. Baker(University of California, Los Angeles), Lian Yi(Southwest Hospital), Fabian Fröhlich(The Francis Crick Institute), Sang Kyun Lim(Harvard University), Christopher Chidley(Harvard University)
Cell Systems
October 27, 2020
Cited by 117


Related Papers